Introduction {#s1}
============

Cognitive deficits are considered to be a core symptom of schizophrenia ([@CIT0021]; [@CIT0027]), yet they remain particularly resistant to treatment ([@CIT0062]). In fact, cognitive dysfunction is often present long before onset of the full clinical syndrome ([@CIT0040]), and the neurodevelopmental hypothesis of schizophrenia posits that cognitive deficits are, in these cases, a proximal manifestation of aberrant brain maturation ([@CIT0045]; [@CIT0041]). An animal model with face, construct, and predictive validity for the cognitive signs of schizophrenia would be of great value in both understanding the neurobiology of these deficits and discovering new treatment options.

One such model, created by repeatedly administering the psychomimetic *N*-methyl-[d]{.smallcaps}-aspartate (NMDA) receptor antagonist phencyclidine (PCP) to adult nonhuman primates ([@CIT0032]), leads to schizophrenia-like prefrontal cortex-dependent cognitive dysfunction, such as deficits in working memory and response inhibition ([@CIT0033]; [@CIT0006]; [@CIT0018]), indicating face validity. The neurochemical and morphological alterations in the prefrontal cortex of monkeys treated repeatedly with PCP also resemble the alterations found in this brain region of patients with schizophrenia. For example, 1 to 2 weeks following PCP exposure in monkeys, there is downregulation of the mesocortical dopamine (DA) system ([@CIT0032]), fewer parvalbumin-containing GABA interneurons ([@CIT0050]), and loss of excitatory spine synapses on pyramidal neurons ([@CIT0017]) compared with the same measures in control subjects. Thus, the primate repeated exposure PCP model has construct validity with both the glutamate hypothesis ([@CIT0068]; [@CIT0049]) and the hypo-DA hypothesis of schizophrenia ([@CIT0013]; [@CIT0035]; [@CIT0001]) and also presents with loss of parvalbumin interneurons ([@CIT0059]) and decreased dendritic spine density on pyramidal neurons that are observed in the dorsolateral prefrontal cortex (DLPFC) in schizophrenia ([@CIT0023]; [@CIT0036]). Furthermore, predictive validity is demonstrated by reversal of the cognitive deficits induced by repeated PCP exposure in monkeys by agents ([@CIT0033]; [@CIT0018]) that are clinically effective ([@CIT0062]; [@CIT0011]).

During the juvenile and adolescent periods of development, the PFC in primates is still undergoing significant maturation, both morphologically and biochemically ([@CIT0024]; [@CIT0029]). This is the time in development when individual symptoms coalesce, leading to a diagnosis of schizophrenia ([@CIT0025]), and also is the age at which the vulnerability to the consequences of psychoactive drugs such as PCP is enhanced ([@CIT0012]). Administration of PCP during this developmental window of risk may more comprehensively or accurately model the neurobiology and cognitive deficits in schizophrenia, so we examined the effects of repeated PCP treatment in monkeys of this age. Although previous studies in rodents have studied the consequences of early life administration of PCP ([@CIT0014]; [@CIT0010]; [@CIT0071]), the primate model offers the opportunity to study a model organism with a protracted adolescent period much more similar to that of humans. Additionally, because the incidence of schizophrenia is significantly higher in males than females ([@CIT0048]), possibly due to the neuroprotective properties of estradiol ([@CIT0046]), we extended the current study to include a comparison of the effects observed following repeated PCP treatment in male and female monkeys.

Our recent data suggest that DA availability in the DLPFC regulates spine synapse number and prefrontal cortex function. Thus, in both the primate PCP model and primate 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model, reduced DA transmission in DLPFC is associated with loss of spine synapses and cognitive deficits ([@CIT0017], [@CIT0019]). The present study also provided us with an opportunity to more rigorously test the relationship between DA signaling in the prefrontal cortex, spine synapse number, and prefrontal cortex-dependent cognition.

We hypothesized that pre-adult monkeys would exhibit a greater impact of PCP treatment than adult monkeys, that males would show enhanced PCP-induced deficits compared with females, and that DA turnover, spine synapse number, and working memory performance will change in unison following PCP treatment.

Methods {#s2}
=======

Animals and PCP Treatment {#s3}
-------------------------

All monkeys (*Chlorocebus sabaeus*, commonly known as vervet monkeys) were born and raised in social housing groups at the St. Kitts Biomedical Research Foundation in the West Indies, a facility approved by the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC). Monkeys were fed Harlan Teklad New Iberia Primate Diet (no. 8773) supplemented with seasonal local fruits. Water was constantly available. Protocols were reviewed and approved in advance by the Institutional Animal Care and Use Committees of both Yale University and St. Kitts Biomedical Research Facility; all studies were conducted in accordance with the U.S. National Institutes of Health Guide for the Care and Use of Laboratory Animals.

Experiment 1: Effect of PCP on DLPFC Spine Synapses during Development {#s4}
----------------------------------------------------------------------

Male monkeys of different ages were treated with either PCP or saline for 2 weeks and euthanized 1 week later. There were 4 controls and 4 PCP-treated monkeys in each of 3 age groups; these groups comprised either peri-adolescent (referred to as juvenile) ([@CIT0069]), late adolescent (referred to as adolescent), or adult monkeys. The treatment schedule was the same as we have used before in all our primate studies on the effects of repeated PCP exposure (eg, [@CIT0032]). This involved 2 intramuscular injections each day for 14 consecutive days of either PCP (0.3mg/kg) or an equal volume of saline (0.1mL/kg). There was no significant difference in weight or age between saline-treated controls and PCP-treated animals for any age group (mean values ± standard deviation for juveniles: 2.7±0.3kg, 2.0±0.4 years; adolescents: 4.9±0.8kg, 3.7±0.2 years; adults: 6.6±0.6kg, 6.1±0.4 years). Animals were euthanized by injection of an overdose of pentobarbital. Brains were perfused in situ with saline, followed by a fixation solution of 4% formaldehyde containing 0.1% glutaraldehyde in 0.1M phosphate buffer, pH 7.4, at room temperature. Formaldehyde solution was prepared from paraformaldehyde no longer than 1 week before use, as recommended ([@CIT0028]). Glutaraldehyde (from a sealed ampoule of 50% concentration, Electron Microscopy Sciences, Hatfield, PA) was added to the fixative solution on the day of the perfusion. After removal, brains were stored at 4°C overnight in 4% buffered formaldehyde solution before transfer to 0.1M phosphate buffer containing 0.1% sodium azide at 4°C. Brains were shipped with ice packs by overnight courier to Yale University for electron microscope (EM) analysis. analysis to determine the number of asymmetric spine synapses in DLPFC (described below).

Experiment 2: Effect of PCP on Spine Synapses, DA Turnover, and Cognition in Male and Female Juvenile Monkeys {#s5}
-------------------------------------------------------------------------------------------------------------

An equal number (8) of male and female juvenile (peri-adolescent, see Experiment 1) monkeys was entered into the study. After all monkeys were responding on the cognitive task with at least 80% accuracy (see below for details of behavior), 4 monkeys of each sex were treated with PCP and 4 of each sex were treated with saline, as described above. There was no significant difference in weight or age between PCP-treated and saline-treated monkeys for either sex (mean values ± standard deviation for males: 2.4±0.3kg, 2.1±0.3 years; females: 2.3±0.2kg, 2.1±0.4 years).

Behavior {#s6}
--------

Working memory was assessed in monkeys using a 2-choice spatial delayed response task ([@CIT0031]). A custom-designed Wisconsin General Test apparatus was fitted directly onto the cage, where an opaque screen separated the monkey from 2 equally spaced wells that could be covered to conceal rewards (ie, a small piece of banana, grape, or apple). A trial began when the screen was raised and the monkey watched the experimenter bait 1 of the 2 wells. The reward was concealed from view (using 2 identical objects placed directly over each well) and the screen lowered and immediately raised (an approximately 0-second delay). Monkeys made a response by displacing 1 of the objects and, when a correct response was made, were allowed to retrieve the reward. The next trial began following a 20-second inter-trial interval. Monkeys completed 30 trials per day where delays and rewarded well were counterbalanced and randomized across trials on each testing day. Once monkeys were achieving \>80% accuracy in the 0-second delay condition (chance performance in this 2 choice task is 50%), they were exposed to a variable delay condition. In this condition, one-third of trials involved an approximately 0-second delay, one-third of trials involved a short delay, and one-third of trials involved a longer delay. One week and 4 weeks after completing the PCP (or saline) injections, monkeys were tested again with variable delay conditions.

Tissue Collection {#s7}
-----------------

Four weeks after PCP or saline treatment, animals were euthanized by an injected overdose of sodium pentobarbital. Brains were perfused in situ with cold saline, then removed and sectioned into 4-mm slabs using a brain mold. Several samples of DLPFC were dissected from the slabs on a refrigerated surface (2°C), placed in labeled cryotubes, and immediately frozen in liquid nitrogen. A slab containing DLPFC was immersion-fixed in formaldehyde solution containing glutaraldehyde for EM, as previously described in detail ([@CIT0019]). Frozen samples were transported to Yale University in a liquid nitrogen tank, where samples were stored in a −70°C freezer. Fixed samples were transported as described above (Experiment 1).

Biochemistry {#s8}
------------

DA and its main metabolite in primate brain, homovanillic acid (HVA) ([@CIT0005]), were extracted from DLPFC samples and electrochemically detected after reverse-phase isocratic high-performance liquid chromatograph (HPLC) separation, as previously described ([@CIT0016]; [@CIT0051]). Quantification was achieved by reference to internal and external standards. The protein content of the centrifuged tissue pellet was measured using the Lowry method, and concentrations of DA and HVA were expressed as nanogram per milligram protein.

Electron Microscopy {#s9}
-------------------

The number of asymmetric (excitatory) spine synapses in layers 2/3 of Walker's area 46 of DLPFC was calculated as previously published ([@CIT0020]). Layers 2/3 of DLPFC were examined, because pyramidal neurons in these layers send collaterals to associational cortical regions ([@CIT0030]), and asymmetric spine density in these layers has been correlated with working memory performance in primates ([@CIT0057]). In addition, in primates there is a relatively dense DA innervation of layers 2/3 in DLPFC ([@CIT0038]), which appears to regulate asymmetric spine synapse number ([@CIT0019]). Asymmetric spine synapses were counted according to the rules of the disector technique ([@CIT0044]) within an unbiased counting frame superimposed onto each electron micrograph. Asymmetric spine synapses were distinguished from symmetric synapses by prominent postsynaptic densities and wider synaptic junctions, with the presence of fewer mitochondria, as well as by uniformly round synaptic vesicles.

Estradiol Level {#s10}
---------------

Quantification of plasma estradiol levels was achieved using a sensitive competitive binding enzyme-linked immunosorbent assay (ELISA) (Kit EIA4399, DRG International, Springfield, NJ). Each plasma sample was extracted prior to analysis for 3 reasons: (1) to increase the reliability of measurements in samples with low levels of estradiol as recommended ([@CIT0003]), (2) to obviate interferences from hemolyzed plasma samples, and (3) to allow the sample to be concentrated by dissolving the extracted residue in a smaller volume than the initial sample. Extraction was achieved by vortexing 0.5mL plasma with 10 volumes of hexane and ethyl acetate (3:2) for 30 seconds in silanized glass tubes ([@CIT0015]). After centrifugation, the tube was placed in dry ice and the supernatant poured off the frozen aqueous layer. The organic phase was dried under nitrogen in a silanized glass tube, and the residue was reconstituted in 0.25mL steroid-free serum. A separate experiment showed that recovery of estradiol with this procedure was 95%. Duplicate 100-µL samples were entered in the ELISA assay along with standards and blanks.

Brain Derived Neurotrophic Factor (BDNF) messenger RNA (mRNA) {#s11}
-------------------------------------------------------------

Total RNA was extracted by using a QIAGEN RNAeasy kit (QIAGEN). One µg of total RNA was subjected to complementary DNA (cDNA) synthesis using a High Capacity cDNA Reverse transcription Kit (Applied Biosystems, Carlsbad, CA). Real-time PCR with 10-fold diluted cDNA was performed using the LightCycler 480 (Roche) and Taqman Gene Expression Master mix (Applied Biosystems) in a 20-μL reaction volume in triplicate. BDNF and Beta-actin (both Applied Biosystems) primers were used in this study. Beta-actin was used as a reference gene. The calculations of average crossing point values, standard deviations, and resulting expression ratios for BDNF gene were performed using the Roche LightCycler 480 software.

BDNF Levels {#s12}
-----------

The BDNF concentration in DLPFC of each monkey was measured using a sandwich ELISA system (BDNF Emax Immunoassay system, catalog G7610, Promega Corporation, Madison, WI). Samples were processed according to the protocol, except that individual peptidase inhibitors (phenylmethylsulfonyl fluoride (PMSF), aprotinin, leupeptin) in the lysis buffer were replaced with a commercial cocktail of peptidase inhibitors (Complete Protease Inhibitor Tablets, EDTA-free, Roche Diagnostics Corporation, Indianapolis, IN).

Statistics {#s13}
----------

Statistical significance of the data was determined using either Prism (software version 6.0d; GraphPad Software, La Jolla, CA) or SPSS (software version 21; SPSS Inc, Chicago, IL). The Results section contains the specifics of each analysis. In all cases, statistical significance was set as *P*\<.05.

Results {#s14}
=======

Experiment 1 {#s15}
------------

The first study was conducted to assess whether repeated PCP treatment induced a greater effect on spine synapses in the DLPFC of pre-adult monkeys compared with adult monkeys. Because of the possible neuroprotective effect of estradiol, only male monkeys were used so that circulating estradiol levels would vary little within each age group. These animals were euthanized 1 week after the final PCP or saline injection. The endpoint measure was the number of spine synapses in DLPFC. We have found this to be the most sensitive index of the impact of PCP on DLPFC in terms of variability between animals and percent change from control levels. The data were analyzed by 2-way analysis of variance (ANOVA), which indicated significant effects of treatment \[F(1,18)=135, *P*\<.0001\], age \[F(2,18)=27.2, *P*\<.0001\], and an interaction between these factors \[F(2,18)=5.1, *P*\<.05\], which is shown in [Figure 1](#F1){ref-type="fig"}. In addition, there was a difference in number of asymmetric spine synapses in DLPFC among the control groups of differently aged monkeys \[ANOVA, F(2,9)=70.2, *P*\<.0001\], with juvenile monkeys possessing a greater number (36.1±1.0x10^9^) than either adolescent (23.4±0.6x10^9^) or adult (23.3±1.0x10^9^) groups \[Tukey's multiple comparison test, *P*\<.0001\].

![Impact of phencyclidine (PCP) on asymmetric spine synapses in dorsolateral prefrontal cortex (DLPFC) is dependent on age of the monkey. The effect of PCP on the mean number of spine synapses (±SEM) is shown at 1 week after treatment. \* indicates a significant difference from age-matched control value. Both juvenile and adolescent male monkeys had greater loss of synapses compared with adult male monkeys, as indicated by †. The number of spine synapses in juvenile control monkeys was greater than in control monkeys of adolescents and adults, indicated by Ω.](ijnppy_pyu048_f0001){#F1}

Other analysis of the data revealed that there was significant difference between the 3 groups of monkeys (juvenile, adolescent, and adult) in terms of the proportion of spine synapses lost at 1 week following PCP (Kruskal-Wallis statistic=7.5, *P*=.01). Subsequent testing showed that juvenile and adolescent monkeys each exhibited a greater difference between the number of spine synapses in PCP-exposed compared with controls than did the adult group (2-tailed Mann-Whitney test, *P*\<.05).

Experiment 2 {#s16}
------------

Based on the result of Experiment 1, the next study (Experiment 2) used juvenile monkeys to compare the response to PCP treatment in male and female monkeys and to examine the relationship between spine synapses in DLPFC, DA turnover in DLPFC, and performance on the spatial delayed response task that is dependent on the DLPFC ([@CIT0007]). It became possible for us to make measurements of DA turnover and spine synapses in the same monkey when we established a modified immersion fixation technique ([@CIT0019]).

Behavior {#s17}
--------

Performance in the 2-choice spatial delay response task was examined using a repeated-measures multivariate analysis of variance (MANOVA) with the average accuracy before, 1 week after, and 4 weeks after PCP (or saline) injections at the middle and longest delays entered as repeated measures and drug and sex as between-subject factors. The effect of drug on accuracy in the spatial delay response task revealed a significant drug by sex by time point interaction \[F(4,46)=2.75; *P*=.04\] with no significant drug by time point \[F(4,46)=0.91; *P*=.47\] or sex by time point \[F(4,46)=1.39; *P*=.25\] interactions detected. Univariate analyses revealed that the 3-way interaction was strongest for accuracy in the middle delay \[F(2,24)=5.44; *P*=.01\]. To determine if sex was a significant factor in the PCP or saline groups, similar to our biochemical findings, an omnibus MANOVA was conducted independently for each drug group using the same accuracy measures and with sex as the between-subjects factor. In the saline group, the sex by time point interaction was not significant \[F(4,22)=0.18; *P*=.94\]; however, in the PCP group, there was a significant sex by time point interaction \[F(4,22)=3.57; *P*=.02\], which was significant for the middle delay \[middle delay: F(2,12)=8.88; *P*=.004; longest delay: F(2,12)=0.26; *P*=.78\]. Post-hoc 1-tailed *t* tests, comparing the accuracy of PCP-exposed males to that of PCP-exposed females, indicated that the accuracy of PCP-exposed male monkeys was lower than that of PCP-exposed female monkeys at the 4-week time point \[t(6)=−2.25; *P*=.03\] ([Figure 2](#F2){ref-type="fig"}) but not at the behavioral assessment 1 week following the PCP injections \[t(6)=0.16; *P*=.88\].

![Sex difference in cognitive performance 4 weeks following phencyclidine (PCP) treatment in juvenile monkeys. Mean accuracy (±SEM) was significantly lower in male monkeys exposed to PCP compared with female monkeys exposed to PCP. Accuracy did not differ between male and female monkeys exposed to saline. \* indicates a significant difference from female PCP monkeys.](ijnppy_pyu048_f0002){#F2}

Biochemistry {#s18}
------------

Analysis of the biochemical data revealed that at 4 weeks after PCP treatment, the HVA/DA ratio in the DLPFC was lower in male, but not female, monkeys compared with sex- and age-matched controls ([Figure 3](#F3){ref-type="fig"}). Thus, there was a significant interaction between drug treatment and sex in a 2-way ANOVA \[F(1,12)=8.2, *P*=.01\], and a subsequent 2-tailed unpaired t-test confirmed a lower HVA/DA ratio in the male PCP-treated monkeys than in male saline-treated monkeys \[t(6)=2.6, *P*\<.05\] along with no change in the female monkeys. A separate 2-way ANOVA showed that there was no treatment or sex difference in DA tissue concentration in DLPFC, supporting the validity of HVA/DA ratio as an index of DA turnover.

![Sex difference in the dopamine (DA) turnover in dorsolateral prefrontal cortex (DLPFC) 4 weeks following phencyclidine (PCP) in juvenile monkeys. DA turnover, assessed by mean HVA/DA ratio (±SEM), was significantly lowered in male monkeys exposed to PCP unlike in female monkeys exposed to PCP. There was no difference in the HVA/DA ratio between male and female monkeys exposed to saline. \* indicates a significant difference from female PCP monkeys.](ijnppy_pyu048_f0003){#F3}

Electron Microscopy {#s19}
-------------------

The number of asymmetric spine synapses was entered into a 2-way ANOVA, and this reported a significant interaction between the treatment and sex \[F(1,12)=19.0, *P*\<.001\], which is shown in [Figure 4](#F4){ref-type="fig"}. A subsequent 2-tailed unpaired *t* test indicated a significantly lower number of spine synapses in male \[t(6)=5.4, *P*\<.005\] but not female PCP-treated monkeys compared with appropriate controls.

![Sex difference in the number of spine synapses in dorsolateral prefrontal cortex (DLPFC) 4 weeks following phencyclidine (PCP) in juvenile monkeys. Mean number of asymmetric spine synapses (±SEM) was significantly lowered in layer 2/3 of DLPFC in male monkeys exposed to PCP unlike in female monkeys exposed to PCP. There was no difference in number of spine synapses between male and female monkeys exposed to saline. Mean number of asymmetric spine synapses in control males was 21.7x10^9^ and 22.7x10^9^ in control females. \* indicates a significant difference from female PCP monkeys.](ijnppy_pyu048_f0004){#F4}

Correlations {#s20}
------------

The Pearson correlation coefficient was derived to test the strength of linear relationships between HVA/DA ratio in DLPFC, number of spine synapses in DLPFC, and working memory accuracy, although it is recognized that a nonlinear model may actually describe these associations better. As shown in [Figure 5](#F5){ref-type="fig"}, the 2-tailed Pearson's correlation coefficient between HVA/DA ratio in DLPFC and number of spine synapses in DLPFC was statistically significant \[r(14)=0.64, *p*\<.01\]. In addition, the 2-tailed Pearson's correlation coefficient between the accuracy on the cognitive test and HVA/DA ratio in DLPFC among all monkeys was significant \[r(14)=0.54, *P*\<.05\], as is depicted in [Figure 5](#F5){ref-type="fig"}. Furthermore, the Pearson's correlation coefficient between the accuracy on the cognitive test and number of spine synapses in DLPFC among all monkeys ([Figure 5](#F5){ref-type="fig"}) was significant \[r(14)=0.56, *P*\<.05\]. The correlations are only meaningful if there is a reasonable spread of values for both variables. Inspection of the distribution of individual points on the graphs in [Figure 5](#F5){ref-type="fig"} shows that this appears to be so, although the values for the male PCP-treated animals tended to be clustered closer together relative to values from other groups.

![Correlations between dopamine (DA) turnover in dorsolateral prefrontal cortex (DLPFC), accuracy on a working memory task, and number of asymmetric spine synapses in DLPFC. Significant correlations existed between each pair of these 3 outcome measures following phencyclidine (PCP) in male and female juvenile monkeys.](ijnppy_pyu048_f0005){#F5}

Estradiol Levels {#s21}
----------------

A Mann-Whitney test confirmed that plasma estradiol levels were significantly higher in female monkeys compared with male monkeys receiving PCP (median values 19.0 vs 5.0 pg/mL; *P*\<.03).

BDNF mRNA {#s22}
---------

A 2-way ANOVA with BDNF mRNA as the dependent variable identified a significant interaction between treatment and sex \[F(1,12)=7.7, *P*\<.05\], and subsequent analysis by Tukey's multiple comparison test revealed a significant difference only between saline and PCP-treated males (*P*\<.05), as shown in [Figure 6](#F6){ref-type="fig"}.

![Lower BDNF mRNA in male phencyclidine (PCP)-exposed monkeys compared with saline-treated controls. Data (mean ±SEM) are adjusted for expression of actin mRNA. \* indicates significant difference from controls.](ijnppy_pyu048_f0006){#F6}

BDNF Levels {#s23}
-----------

Although statistical analysis did not detect an effect of PCP on BDNF levels, DLPFC from all male monkeys (regardless of treatment) contained a lower BDNF concentration \[*t* test, *P*\<.05\] than in all female monkeys (2.8±0.3 vs 4.4±0.6 pg/mg protein).

Discussion {#s24}
==========

The current studies produced several new findings. The first was that juvenile and adolescent male monkeys demonstrated a greater loss of spine synapses in DLPFC than adult male monkeys when treated with our standard regimen of PCP. Subsequent studies conducted in male juvenile monkeys revealed that working memory impairments existed at 4 weeks following PCP treatment and were associated with both lower DA turnover in DLPFC and fewer dendritic spine synapses in DLPFC. In contrast, female juvenile monkeys displayed no working memory deficits at 4 weeks after PCP treatment, and in addition, DA turnover and spine synapse number in DLPFC of female monkeys exposed to PCP were not significantly different from those of controls. In the combined group of male and female monkeys, significant linear correlations were detected between DA turnover, synapse number, and cognitive performance. Together, these results enhance the validity of the primate PCP model of cognitive deficits in schizophrenia and strengthen the argument that DA levels in DLPFC regulate spine synapse number and working memory performance.

Greater Impact of PCP in Juvenile Monkeys {#s25}
-----------------------------------------

During the juvenile and adolescent phase of development, the prefrontal cortex exhibits marked changes in structure and neurochemistry, which is reflected in altered behavior and pharmacological responses compared with adults ([@CIT0067]). Indeed, PCP is known to exert more potent effects in developing rodent brain compared with the mature brain ([@CIT0054]; [@CIT0052]). There is no indication that altered metabolism of PCP accounts for the greater impact of PCP on spine synapses observed in juvenile monkeys compared with adults in the current study. Thus, the observed difference may be connected to the existence of supernumerary dendritic spines in the cerebral cortex during the pre-adult period in primates. During puberty in primates, selective elimination of the initially overproduced number of synaptic spine in cerebral cortex occurs, and this synaptic pruning continues into early adulthood ([@CIT0008]; [@CIT0056]). Other maturation processes that occur prior to adulthood include changes to transmitter systems that subserve the actions of PCP in the prefrontal cortex, namely the DA, glutamate, and GABA systems ([@CIT0067]), in addition to PCP-binding sites ([@CIT0060]). Such adaptations within the primate PFC probably contribute to the exaggerated response to PCP noted in juvenile monkeys in the present study.

Relationship between Cognition, DA, and Spine Synapses {#s26}
------------------------------------------------------

We have previously postulated that DA availability is an important regulator of the number of asymmetric spine synapses in DLPFC. This was based on the marked loss of spine synapses in DLPFC following either a decrease in DA turnover or a loss of DA innervation ([@CIT0017], [@CIT0019]). However, data from the present study are the strongest evidence so far in favor of this interpretation. Here, we demonstrated that at 4 weeks after PCP treatment, males had working memory deficits together with a decrease in DA turnover and loss of spine synapses in DLPFC. In contrast, PCP-treated females did not display working memory impairments and also did not have altered DA turnover or loss of spine synapses in DLPFC. Indeed, in the combined group of males and females, there was a significant correlation between DA turnover and number of spine synapses in layer 2/3 of DLPFC, between DA turnover and cognitive performance, and between number of spine synapses in layer 2/3 of DLPFC and cognition. We previously noted a significant correlation between DA turnover in DLPFC and cognitive performance in PCP-treated monkeys performing a different PFC-dependent cognitive test, the object retrieval/detour task ([@CIT0032]). In addition, another group ([@CIT0057]) observed a loss in the number of spine synapses in layer 2/3 of DLPFC of aged monkeys that correlated with cognitive performance on a delayed nonmatching to sample task. Thus, the current study provides strong support for the hypothesis that DA availability regulates spine synapse number in DLPFC.

This supposition raises the question of how a decrease in dopaminergic signaling leads to a loss of asymmetric spine synapses. As in schizophrenia, the mechanism underlying the abnormal PFC DA system in the PCP model is not clear. PCP's primary pharmacological property is blockade of neurotransmission at NMDA-type glutamate receptors, so other biochemical changes, such as alteration in DA system, are generally assumed to be secondary to this action. As the glutamate hypothesis of schizophrenia is largely based on the similarity between behavioral effects of PCP and symptoms of schizophrenia, explanations of perturbation in the DA system in schizophrenia have also been attributed as secondary to a hypofunction of the glutamate system in the PFC ([@CIT0039]; [@CIT0070]; [@CIT0022]; [@CIT0049]). DA tone is known to regulate NMDA receptor subunit trafficking in pyramidal neurons. In fact, dendritic spines are enriched with D1 and NMDA receptors, and D1 signals have been shown to enhance NMDA receptor-mediated current on dendritic spines in PFC ([@CIT0042]). Thus, it seems likely that the strong correlation between DA turnover and spine synapse number is due to DA regulation of spine synapse number rather than vice versa. Additional support for this contention derives from studies in the MPTP model of parkinsonian cognitive deficits in monkeys ([@CIT0019]). The pharmacological actions of MPTP are quite specific for the DA system, and in cognitively impaired MPTP-treated monkeys with no overt motor deficits, there is a loss of DA concentration in the DLPFC together with a decrease in number of spine synapses. Thus, the commonalty in the PCP and MPTP models is reduction in DA transmission and marked loss of spine synapses in DLPFC.

Excitatory synapses on dendritic spines of pyramidal neurons are critical components that regulate the outflow of information from the DLPFC and the function of the DLPFC. In fact, the loss of asymmetric spine synapses in DLPFC of aged monkeys compared with younger monkeys is associated with a decrease in the frequency of spontaneous excitatory postsynaptic current ([@CIT0057]). The present data suggest that in the PCP model (and maybe in schizophrenia), strategies that directly or indirectly reinstate appropriate DA transmission may be necessary to restore the synapse or spine loss and function of the PFC.

Recovery in Female Monkeys {#s27}
--------------------------

It is not yet known why juvenile male, but not female, monkeys exhibited PCP-induced behavioral, biochemical, and synaptic changes at the end of this study. There is no indication that pharmacokinetic factors are responsible; in fact, studies in rodents demonstrated that after the same dose of PCP, the concentration of drug in the female rat brain was higher than in the male rat brain and that the half-life of PCP in the brain and plasma was longer in female rats than in male rats. These differences were attributed to a decreased ability of females to metabolize the drug ([@CIT0053]; [@CIT0063]). However, it is noteworthy that sex differences in metabolism of PCP have not been found in humans ([@CIT0055]). We used our standard dose regimen of PCP administration in the current studies, so we do not yet know at what dose of PCP female juvenile monkeys might exhibit the changes observed here in juvenile males. The most straightforward explanation for the sex-dependent effects of PCP in this study is based on the protective and reparative effects that estradiol and progesterone can exert in the CNS ([@CIT0004]; [@CIT0064]). Although the level of estradiol is substantially lower in juveniles than in adults, circulating estradiol concentration was higher in females than males, which is consistent with a role of peripherally derived hormone in the recovery. However, the contribution of locally synthesized estradiol or progesterone in the brain cannot be discounted ([@CIT0047]; [@CIT0061]; [@CIT0058]).

The existence of an estrogen response element-like motif in the BDNF gene indicates that estradiol regulates BDNF expression levels ([@CIT0065]), and this interaction provides a plausible explanation for the relatively rapid recovery of spine synapse number in female PCP-treated monkeys. This is because mRNA for BDNF, which has an established critical role in regulating spine plasticity and spine synapse number (reviewed by [@CIT0043]; [@CIT0066]) was reduced in male, but not female, PCP-treated monkeys compared with controls. Analysis of BDNF levels by ELISA did not reveal the same profile of changes as BDNF mRNA levels by quantitative PCR, although mean BDNF level in DLPFC in all females (regardless of treatment) was higher than in all males, which is still consistent with a sex-dependent protective effect of BDNF on spine synapses and working memory in this model. Interestingly, BDNF is reduced in DLPFC from patients with schizophrenia ([@CIT0072]; [@CIT0026]). In addition, there is evidence that estradiol controls expression of TrkB, the protein kinase receptor for BDNF, which provides for an additional possible level of estradiol-mediated regulation of BDNF signaling ([@CIT0009]). In view of the apparent role of estradiol in maintaining TH-expression in monkey DLPFC ([@CIT0037]), it is also possible that estradiol plays a role in the restoration of DA turnover in PCP-treated female monkeys. Furthermore, DA itself in some models has been reported to activate BDNF expression ([@CIT0073]). So, it is possible to construct a model in which BDNF expression is relatively higher in female monkeys as a result of direct and indirect actions of estradiol in DLPFC and that BDNF signaling induces spine synapse recovery, which in turn accounts for improved working memory performance compared with male PCP-treated monkeys. However, it is recognized that estradiol is certainly not the only determinant of BDNF expression in either the PCP model or schizophrenia.

The parallel between the sex-dependent effect observed in the primate PCP model of schizophrenia and the lower incidence of schizophrenia in females is intriguing. Evidence for the latter includes meta-analyses that have reported men having an approximately 40% greater chance of developing schizophrenia than women ([@CIT0002]; [@CIT0048]). In addition, the onset of schizophrenia is earlier and the rate of progression steeper for males than females, and particularly relevant is the observation that women have a second peak of incidence following menopause ([@CIT0046]). Although all the biochemical mechanisms underlying the sex-dependent effects in the PCP model and in schizophrenia are not yet known, this apparent similarity extends the correspondence between the model and the disorder.

The current findings strengthen the validity of the juvenile primate PCP model and highlight its potential usefulness in developing novel treatments for the cognitive deficits associated with schizophrenia. Such progress will be dependent on understanding the molecular underpinnings of the synaptic changes in the primate PCP model and identifying pharmacological strategies to ameliorate the maladaptive remodeling.
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